Search results
Halozyme Therapeutics Scores RS Rating Jump To 91
Investor's Business Daily· 6 days agoOver 100 years of market history shows that the top-performing stocks often have an RS Rating of above 80 as they begin their largest climbs. Is Halozyme...
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
Motley Fool via Yahoo Finance· 4 days agoTherefore, while both stocks are a good option for those seeking exposure to biotech, Viking is the...
Should You Buy the Dip on Compass Pathways Stock?
Motley Fool via Yahoo Finance· 2 days agoIt didn't report any bad news on that day, nor has it done so this year. So is this a great opportunity to buy the dip, or is the recent decline a...
Why Moderna Stock Is a No-Brainer Buy Right Now
The Motley Fool via AOL· 4 days agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only $4 billion this year. The real story for Moderna is much better than that ...
Why Moderna Stock Is a No-Brainer Buy Right Now | The Motley Fool
The Motley Fool· 4 days agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only...
These 2 Words Are Why Intellia Therapeutics Could Be a Smart Buy Right Now
Motley Fool via Yahoo Finance· 6 days agoBut it has no revenue outside its collaboration agreements rightnow. And regrettably, there is a...
REGN, CI, BSX: Which “Strong Buy” Healthcare Stock Is the Best Bet?
TipRanks via Yahoo Finance· 1 day agoFor value investors looking to take a “break” from the euphoric technology stocks, many of which may...
3 Reasons to Buy Moderna Stock
Motley Fool via Yahoo Finance· 6 days agoThough that still trails the S&P 500, Moderna should be able to generate solid returns for a long time to patient investors. Should you invest $1,000 in...
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 17 hours agoFor Verona, the potential approval in COPD treatment could help sales skyrocket. In 2024, analysts...
Dow Jones Slides After Inflation Data, Jobless Claims; Tesla Surges On Elon Musk Tweet
Investor's Business Daily· 15 hours agoNow is an important time to read The Big Picture column amid the ongoing stock market action. Also,...
